(Q35209308)

English

Clinical significance of high-density lipoproteins and the development of atherosclerosis: focus on the role of the adenosine triphosphate-binding cassette protein A1 transporter

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1 reference

Europe PubMed Central

Clinical significance of high-density lipoproteins and the development of atherosclerosis: focus on the role of the adenosine triphosphate-binding cassette protein A1 transporter (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

adenosine triphosphate

0 references

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

H Bryan Brewer

1

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Silvia Santamarina-Fojo

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

92

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

4B

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

10K-16K

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

High-density lipoprotein--the clinical implications of recent studies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Familial lipoprotein disorders in patients with premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Cellular localization and trafficking of the human ABCA1 transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Apolipoprotein specificity for lipid efflux by the human ABCAI transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Regulation and activity of the human ABCA1 gene in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

The ABCA1 transporter functions on the basolateral surface of hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Multicompartmental analysis of cholesterol metabolism in man. Characterization of the hepatic bile acid and biliary cholesterol precursor sites

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Central role of high density lipoprotein in plasma free cholesterol metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

An in vivo evaluation in man of the transfer of esterified cholesterol between lipoproteins and into the liver and bile.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

The role of high-density lipoproteins in oxidation and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Effects of inflammation on high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900769-0

7 January 2021

Identifiers

10.1016/S0002-9149(03)00769-0

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35209308&oldid=1948166386"